IndusInd Bank Share Price in Focus After It Reports Q2 FY27 Financial Update

On October 5, 2026, IndusInd Bank released its financial update for the quarter ending September 30, 2026, as per the exchange filings.
The bank reported net advances of ₹3,62,393 crore, reflecting an 11.2% year-on-year increase and an 11.1% quarter-on-quarter rise. Deposits stood at ₹4,29,038 crore, marking a 10.1% year-on-year growth and a 3.4% quarter-on-quarter increase.
Net Advances and Deposits
As of Quarter Ending September 30, 2026, IndusInd Bank's net advances were ₹3,62,393 crore, showing an 11.2% increase compared to the same period in 2025.
The quarter-on-quarter growth was 11.1% from June 2026. Deposits reached ₹4,29,038 crore, with a 10.1% year-on-year growth and a 3.4% increase from the previous quarter.
Retail Deposits and CASA Ratio
Retail deposits and deposits from small business customers amounted to ₹2,14,504 crore as of September 30, 2026. This is an increase from ₹1,93,591 crore in June 2026 and ₹1,84,144 crore in September 2025.
The CASA ratio, however, decreased to 28.0% from 30.7% in September 2025.
FCNR(B) Deposits and Loans
Under the Reserve Bank of India's FCNR(B) deposit swap facility, IndusInd Bank mobilised FCNR(B) deposits totalling $3.51 billion, approximately ₹33,627 crore.
Loans extended from the bank's Gift City branch against these deposits amounted to $1.73 billion, around ₹16,564 crore.
Additionally, standby letters of credit issued against FCNR(B) deposits totalled $0.50 billion, roughly ₹4,772 crore.
IndusInd Bank Share Price Performance
As of October 06, 2026, at 10:11 AM, IndusInd Bank share price on NSE was trading at ₹894.00, up by 0.83% from the previous closing price.
Conclusion
IndusInd Bank's financial update for September 2026 shows net advances at ₹3,62,393 crore, deposits at ₹4,29,038 crore, and a CASA ratio of 28.0%. Retail deposits reached ₹2,14,504 crore, with FCNR(B) deposits totalling $3.51 billion.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
Published on: Oct 6, 2026, 10:26 AM IST

Team Angel One
- Glenmark Pharma Share Price in Focus; Launches Adapalene Gel Pump Packs
- IEX Share Price in Focus as September 2026 Electricity Trading Volume Rises 10.4%
- Lupin Share Price in Focus After Launching New COPD Inhaler Formoflo-G
- Shyam Metalics Share Price in Focus; September 2026 Sales Show Growth Across Key Segments
- Vedanta Share Price Surges Over 3%; Board to Consider 1st Interim Dividend for FY26-27 On October 8, 2026




